Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02498067 · ClinicalTrials.gov registry record · NA
rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities
A NA study of Sexually Transmitted Infection, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT02498067: Completed NA study of Sexually Transmitted Infection, sponsored by University of Chicago.
NCT02498067 is a NA study of Sexually Transmitted Infection that has completed, run by University of Chicago. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02498067, a NA study of Sexually Transmitted Infection, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will develop a digital application (app)-"rPlan dual protection" (rPlan)-to be used in the clinic waiting room prior to a gynecological and/or contraceptive visit. The goal of this research is to develop the app and conduct a feasibility, acceptability and effectiveness assessment of rPlan to examine improvement in dual protection behaviors, enhancement of contraceptive adherence and continuation, increase of condom use and decrease of sexually transmitted infection (STI) and human immunodeficiency virus(HIV) infection. The research will consist of baseline activities and a 12-week in-clinic survey and STI test, as well as a retrospective chart review.
Primary Outcome
Reported frequency of use of condoms with another contraceptive method in past 3 months 5 option close-ended question, ranging from 1 - none of the time, to 5 - every time
Conditions Studied
Interventions
- BEHAVIORAL rPlan dual protection waiting room app intervention
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02498067 record still lists
NCT02498067 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Sexually Transmitted Infection appearing as the primary indexed condition, and to 1 intervention - of which rPlan dual protection waiting room app intervention is the first listed.
NCT02498067 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02498067 about?
NCT02498067 is a clinical study titled "rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities". The investigators will develop a digital application (app)-"rPlan dual protection" (rPlan)-to be used in the clinic waiting room prior to a gynecological and/or contraceptive visit. The goal of this research is to develop the app and conduct a feasibility, acceptability and effectiveness assessment ...
What is the current status of trial NCT02498067?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2015-07. Estimated completion is 2017-08.
What conditions does trial NCT02498067 study?
This clinical trial studies the following conditions: Sexually Transmitted Infection.
What interventions are being tested in trial NCT02498067?
The interventions under investigation include: rPlan dual protection waiting room app intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02498067?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02498067 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02498067's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia